Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127586801 | 12758680 | 1 | I | 201405 | 20140516 | 20160919 | 20160919 | EXP | FR-ALEXION PHARMACEUTICALS INC-A201401986 | ALEXION | 28.22 | YR | F | Y | 0.00000 | 20160919 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127586801 | 12758680 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
127586801 | 12758680 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
127586801 | 12758680 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
127586801 | 12758680 | 4 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, QW | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | /wk | ||||||
127586801 | 12758680 | 5 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, Q2W | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
127586801 | 12758680 | 6 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1200 MG, EVERY 15 DAYS | 125166 | 1200 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
127586801 | 12758680 | 7 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1500 MG, Q2W | 125166 | 1500 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
127586801 | 12758680 | 8 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 1800 MG, Q2W | 125166 | 1800 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | ||||||
127586801 | 12758680 | 9 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Unknown | 80 UNK, UNK | 0 | ||||||||||
127586801 | 12758680 | 10 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Unknown | UNK | 0 | ||||||||||
127586801 | 12758680 | 11 | C | LOXEN | NICARDIPINE HYDROCHLORIDE | 1 | Unknown | 50 (2 QD) | 0 | ||||||||||
127586801 | 12758680 | 12 | C | ASPEGIC | ASPIRIN DL-LYSINE | 1 | Unknown | 75 UNK, UNK | 0 | ||||||||||
127586801 | 12758680 | 13 | C | TRANDATE | LABETALOL HYDROCHLORIDE | 1 | Unknown | 200 (2 QD) | 0 | ||||||||||
127586801 | 12758680 | 14 | C | ALDOMET | METHYLDOPA | 1 | Unknown | 250 (2 QD) | 0 | ||||||||||
127586801 | 12758680 | 15 | C | CERAZETTE /00754001/ | DESOGESTREL | 1 | Unknown | 0.075 MG, UNK | 0 | .075 | MG | ||||||||
127586801 | 12758680 | 16 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 0 | |||||||||||
127586801 | 12758680 | 17 | C | SPASFON /00765801/ | PHLOROGLUCINOL1,3,5-TRIMETHOXYBENZENE | 1 | Unknown | 0 | |||||||||||
127586801 | 12758680 | 18 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | 0 | |||||||||||
127586801 | 12758680 | 19 | C | SECTRAL | ACEBUTOLOL HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
127586801 | 12758680 | 20 | C | TRIATEC /00885601/ | RAMIPRIL | 1 | Unknown | 0 | |||||||||||
127586801 | 12758680 | 21 | C | AMLOR | AMLODIPINE BESYLATE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127586801 | 12758680 | 1 | Haemolytic uraemic syndrome |
127586801 | 12758680 | 9 | Product used for unknown indication |
127586801 | 12758680 | 11 | Product used for unknown indication |
127586801 | 12758680 | 12 | Product used for unknown indication |
127586801 | 12758680 | 13 | Product used for unknown indication |
127586801 | 12758680 | 14 | Product used for unknown indication |
127586801 | 12758680 | 15 | Product used for unknown indication |
127586801 | 12758680 | 16 | Product used for unknown indication |
127586801 | 12758680 | 17 | Product used for unknown indication |
127586801 | 12758680 | 18 | Product used for unknown indication |
127586801 | 12758680 | 19 | Product used for unknown indication |
127586801 | 12758680 | 20 | Product used for unknown indication |
127586801 | 12758680 | 21 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127586801 | 12758680 | OT |
127586801 | 12758680 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127586801 | 12758680 | Complement fixation abnormal | |
127586801 | 12758680 | Exposure during pregnancy | |
127586801 | 12758680 | Foetal growth restriction | |
127586801 | 12758680 | Hypertension | |
127586801 | 12758680 | Incorrect dose administered | |
127586801 | 12758680 | Pre-eclampsia | |
127586801 | 12758680 | Renal disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127586801 | 12758680 | 1 | 201202 | 0 | ||
127586801 | 12758680 | 6 | 20140324 | 0 | ||
127586801 | 12758680 | 7 | 20140422 | 0 | ||
127586801 | 12758680 | 8 | 20140630 | 0 |